Narrow search
Showing 1 - 10 of 5,470
Cover Image
The Globalization of Innovation : Pharmaceuticals: Can India and China Cure the Global Pharmaceutical Market
Wadhwa, Vivek; Rissing, Ben A.; Gereffi, G.; Trumpbour, John - 2014
decreasing costs. Pharmaceutical firms in India and China are increasingly forging partnerships with these corporations to gain … intellectual property. Several firms in India and China are performing advanced R&D and are moving into the highest-value segments …
Persistent link: https://www.econbiz.de/10014047447
Cover Image
India's import dependence on China in pharmaceuticals : status, issues and policy options
Chaudhuri, Sudip - 2021
India has one of the most advanced pharmaceutical industries among developing countires. Yet India is critically … imports. In the early 1990s, China was relatively a minor source of bulk drugs imports for India. Imports increased since then … and sharply accelerated after the early 2000s. By the mid-1990s, India was able to successfully develop a pharmaceutical …
Persistent link: https://www.econbiz.de/10013466963
Cover Image
Emerging pharmaceutical companies from China, India, and Brazil : from generic drugs to innovation strategies
Cahen, Fernanda Ribeiro - In: Innovation from emerging markets : from copycats to leaders, (pp. 222-255). 2021
Persistent link: https://www.econbiz.de/10012815671
Cover Image
Effects of pharmaceutical price regulation : China's evidence between 1997 and 2008
Wu, Binzhen; Zhang, Qiong; Qiao, Xue - In: Journal of the Asia Pacific economy 20 (2015) 2, pp. 290-329
Persistent link: https://www.econbiz.de/10011378658
Cover Image
The launch strategy choices in China's pharmaceutical market
Gu, Vicky Ching; Burns, James R. - In: International journal of pharmaceutical and healthcare … 10 (2016) 3, pp. 339-356
Persistent link: https://www.econbiz.de/10011620465
Cover Image
China Rx : exposing the risks of America's dependence on China for medicine
Kern, Rosemary G.; Singh, Janardan P. - 2018
"Millions of Americans are taking prescription drugs made in China and don't know it-- and pharmaceutical companies are not eager to tell them. This probing book examines the implications for the quality and availability of vital medicines for consumers." - Provided by publisher
Persistent link: https://www.econbiz.de/10011725359
Cover Image
China's pharmaceutical market: business environment and market dynamics
Brueckner, Michael; Philipp, Marc P.; Luithle, Joachim E. A. - In: The chemical and pharmaceutical industry in China : …, (pp. 91-107). 2005
Persistent link: https://www.econbiz.de/10002960708
Cover Image
The pharmaceutical market in the people's Republic of China in transition : current situation and development trends
Chou, Yu-Wen - 2008
Persistent link: https://www.econbiz.de/10003756813
Cover Image
A Generic Drug Policy as Cornerstone to Essential Medicines in China
World Bank - 2010
Compared with developed economies, health expenditure in China is not particularly high on a per capita basis or as a share of Gross Domestic Product (GDP). Similarly, pharmaceutical expenditure in comparative perspective is not particularly high on a per capita basis or as a percentage of GDP....
Persistent link: https://www.econbiz.de/10012247334
Cover Image
Effects of China's Pharmaceutical Price Regulation between 1997 and 2008
Wu, Binzhen - 2014
This paper uses macro-level data between 1997 and 2008 to evaluate the effects of China's pharmaceutical price regulations. We find that these regulations had short-run effects on medicine price indices, reducing them by less than 0.5 percentage points. The effects could have been slightly...
Persistent link: https://www.econbiz.de/10013066440